Lead, genetic susceptibility, and risk of adult brain tumors

Preetha Rajaraman, Patricia A. Stewart, Jonathan M. Samet, Brian S. Schwartz, Martha S. Linet, Shelia Hoar Zahm, Nathaniel Rothman, Meredith Yeager, Howard A. Fine, Peter M. Black, Jay Loeffler, William R. Shapiro, Robert G. Selker, Peter D. Inskip

Research output: Contribution to journalArticle

Abstract

Background: Although few etiologic factors for brain tumors have been identified, limited data suggest that lead may increase the risk of brain tumors, particularly meningioma. The ALAD G177C polymorphism affects the toxicokinetics of lead and may confer genetic susceptibility to adverse effects of lead exposure. Methods: We examined occupational exposure to lead and risk of brain tumors in a multisite, hospital-based, case-control study of 489 patients with glioma, 197 with meningioma, and 799 non-cancer controls frequency matched on hospital, age, sex, race/ethnicity, and residential proximity to hospital. ALAD genotype was assessed by a Taqman assay for 355 glioma patients, 151 meningioma patients, and 505 controls. Exposure to lead was estimated using a rigorous questionnaire-based exposure assessment strategy incorporating lead measurement and other occupational data abstracted from published articles and reports. Results: Increased risk of meningioma with occupational lead exposure (estimated by odds ratios and 95% confidence intervals) was most apparent in individuals with the ALAD2 variant allele, for whom risk increased from 1.1 (0.3-4.5) to 5.6 (0.7-45.5) and 12.8 (1.4-120.8) for estimated cumulative lead exposures of 1 to 49 μg/m3-y, 50 to 99 μg/m3-y, and ≥100 μg/m3-y, respectively, compared with unexposed individuals (two-sided P trend = 0.06). This relationship became stronger after excluding occupational lead exposures characterized by a low confidence level or occurring in the 10 years before meningioma diagnosis. Occupational lead exposure was not associated with glioma risk. Conclusions: Although our results indicate that lead may be implicated in meningioma risk in genetically susceptible individuals, these results need to be interpreted with caution given the small numbers of exposed cases with a variant genotype.

Original languageEnglish (US)
Pages (from-to)2514-2520
Number of pages7
JournalCancer Epidemiology Biomarkers and Prevention
Volume15
Issue number12
DOIs
StatePublished - Dec 2006

ASJC Scopus subject areas

  • Epidemiology
  • Oncology

Fingerprint Dive into the research topics of 'Lead, genetic susceptibility, and risk of adult brain tumors'. Together they form a unique fingerprint.

  • Cite this

    Rajaraman, P., Stewart, P. A., Samet, J. M., Schwartz, B. S., Linet, M. S., Zahm, S. H., Rothman, N., Yeager, M., Fine, H. A., Black, P. M., Loeffler, J., Shapiro, W. R., Selker, R. G., & Inskip, P. D. (2006). Lead, genetic susceptibility, and risk of adult brain tumors. Cancer Epidemiology Biomarkers and Prevention, 15(12), 2514-2520. https://doi.org/10.1158/1055-9965.EPI-06-0482